Spring Behrouz

Spring Behrouz

Company: Vincere Biosciences

Job title: Co-founder & CEO

Seminars:

Showcasing Experiences with Artificial Intelligence as a New Avenue for Neurodegenerative Target Discovery 12:00 pm

Demonstrating AI facilitation in the accelerated development of Vincere's pipeline of small molecules Analyzing clinical data to guide the optimization of drug development Forward-looking insights on the potential of AI technology platforms to optimize clinical trial strategies, particularly in patient stratificationRead more

day: Conference Day Two - Track One

Roundtable Discussion: How Can Artificial Intelligence be Utilized & Implemented into Discovery Workflows to Identify a Biologically Driven Target? 12:30 pm

More practical and highly interactive breakout roundtables where attendees can crowd-source solutions and share opinions around pre-assigned topic areas. Are there real-world examples of how AI can be utilized to facilitate the following aspects of drug discovery? Predicting how druggable a target is Incorporating AI with biology & bet Predicting brain penetrance of potential therapeutics…Read more

day: Conference Day Two - Track One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.